Discussion
Once-weekly preventive treatment with Altuviiio (efanesoctocog alfa) safely reduced bleeding rates while maintaining protective clotting factor levels without triggering neutralizing antibodies in pediatric patients with hemophilia A. That’s according to a real-world study that reviewed data from 22 boys at the University…